Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01 déc. 2017 16h30 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
18 mai 2017 16h30 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., May 18, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...